Waverley Pharma (WAVE) Stock Statistics & Valuation Metrics

Waverley Pharma has a market cap or net worth of C$810.00K. The enterprise value is C$3.55M.

Waverley Pharma has 54,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Waverley Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Waverley Pharma is ―. Waverley Pharma’s PEG ratio is ―.

In the last 12 months, Waverley Pharma had revenue of ― and earned -2.22M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Waverley Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Waverley Pharma upcoming earnings date is Aug 20, 2026, After Close (Confirmed).

Waverley Pharma as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Waverley Pharma has paid ― in taxes.

Waverley Pharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Waverley Pharma has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Waverley Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―